Zhengye Biotechnology Holding (ZYBT) Current Taxes (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Current Taxes of $330627.6 for Q4 2025, up 14.95% year-on-year from $287619.7 in Q4 2024, and up 8.76% on a QoQ basis from $304000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Current Taxes (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Current Taxes for 3 consecutive years, with $330627.6 the latest figure, recorded in Q4 2025.
- Quarterly Current Taxes rose 14.95% year-over-year to $330627.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $330627.6 (up 14.95% YoY) and the FY2025 annual result came in at $335000.0, up 18.37% from the prior year.
- Current Taxes grew to $330627.6 in Q4 2025 per ZYBT's latest filing, from $304000.0 in the prior quarter.
- Over the last five years, Current Taxes for ZYBT reached as high as $330627.6 in Q4 2025 and fell as low as $287619.7 in Q4 2024.
- A 3-year average of $310248.5 and a median of $311373.3 in 2023 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2024 — Current Taxes fell 9.77% — and 2025, when it gained 14.95%.
- Year by year, Current Taxes stood at $318746.6 in 2023, then declined by 9.77% to $287619.7 in 2024, then rose by 14.95% to $330627.6 in 2025.
- According to Business Quant data, Current Taxes over the past three periods registered $330627.6, $304000.0, and $287619.7 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 85.93 Mn | - | 330,627.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 330,627.65 |
| Jun 30, 2025 | 304,000.00 |
| Dec 31, 2024 | 287,619.68 |
| Dec 31, 2023 | 318,746.57 |